MX9207420A - Moleculas de fusion solubles, con enlace especifico para las moleculas de adhesion de las celulas. - Google Patents

Moleculas de fusion solubles, con enlace especifico para las moleculas de adhesion de las celulas.

Info

Publication number
MX9207420A
MX9207420A MX9207420A MX9207420A MX9207420A MX 9207420 A MX9207420 A MX 9207420A MX 9207420 A MX9207420 A MX 9207420A MX 9207420 A MX9207420 A MX 9207420A MX 9207420 A MX9207420 A MX 9207420A
Authority
MX
Mexico
Prior art keywords
molecules
soluble fusion
cell adhesion
specific link
fusion molecules
Prior art date
Application number
MX9207420A
Other languages
English (en)
Inventor
Alejandro A Aruffo
Nitin Damle
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX9207420A publication Critical patent/MX9207420A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70528CD58
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74Inducing cell proliferation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/32Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polyesters Or Polycarbonates (AREA)
MX9207420A 1991-12-20 1992-12-18 Moleculas de fusion solubles, con enlace especifico para las moleculas de adhesion de las celulas. MX9207420A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/811,129 US5861151A (en) 1991-12-20 1991-12-20 Soluble fusion molecules with binding specificity for cell adhesion molecules

Publications (1)

Publication Number Publication Date
MX9207420A true MX9207420A (es) 1993-06-01

Family

ID=25205654

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207420A MX9207420A (es) 1991-12-20 1992-12-18 Moleculas de fusion solubles, con enlace especifico para las moleculas de adhesion de las celulas.

Country Status (21)

Country Link
US (1) US5861151A (es)
EP (1) EP0619843B1 (es)
JP (1) JP3414397B2 (es)
KR (1) KR940703921A (es)
AT (1) ATE190353T1 (es)
AU (1) AU678144B2 (es)
CA (1) CA2123303C (es)
DE (1) DE69230762T2 (es)
DK (1) DK0619843T3 (es)
ES (1) ES2143499T3 (es)
FI (1) FI113278B (es)
GR (1) GR3033474T3 (es)
IE (1) IE922926A1 (es)
IL (1) IL104117A (es)
MX (1) MX9207420A (es)
NO (1) NO313883B1 (es)
NZ (1) NZ245473A (es)
PT (2) PT619843E (es)
TW (1) TW246690B (es)
WO (1) WO1993013210A1 (es)
ZA (1) ZA929595B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US5932214A (en) * 1994-08-11 1999-08-03 Biogen, Inc. Treatment for inflammatory bowel disease with VLA-4 blockers
GB9914650D0 (en) * 1999-06-24 1999-08-25 Angyogene Pharmaceuticals Ltd Chimeric proteins mediating targeted apoptosis
WO2001007084A1 (en) * 1999-07-23 2001-02-01 Regents Of The University Of California Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery
DK1436003T3 (da) * 2001-05-24 2010-03-15 Zymogenetics Inc TACI-immunoglobulin-fusionsproteiner
KR100453877B1 (ko) 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 TNFR/Fc 융합 단백질, 상기 단백질을 코딩하는 DNA, 상기 DNA를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
US20050069549A1 (en) 2002-01-14 2005-03-31 William Herman Targeted ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0365837B1 (en) * 1988-09-28 1995-08-02 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
ES2097747T3 (es) * 1989-03-09 1997-04-16 Blood Res Center Molecula de adhesion intercelular 2 y sus ligandos de union.

Also Published As

Publication number Publication date
EP0619843A1 (en) 1994-10-19
CA2123303A1 (en) 1993-07-08
EP0619843B1 (en) 2000-03-08
IL104117A0 (en) 1993-05-13
ZA929595B (en) 1993-08-19
JPH07502413A (ja) 1995-03-16
PT619843E (pt) 2000-08-31
JP3414397B2 (ja) 2003-06-09
DE69230762D1 (de) 2000-04-13
ES2143499T3 (es) 2000-05-16
NO313883B1 (no) 2002-12-16
TW246690B (es) 1995-05-01
IE922926A1 (en) 1993-06-30
FI942943A0 (fi) 1994-06-17
NZ245473A (en) 1995-08-28
IL104117A (en) 1998-12-27
NO942320L (no) 1994-06-17
FI113278B (fi) 2004-03-31
DK0619843T3 (da) 2000-06-05
NO942320D0 (no) 1994-06-17
US5861151A (en) 1999-01-19
FI942943A (fi) 1994-06-17
ATE190353T1 (de) 2000-03-15
AU3327293A (en) 1993-07-28
PT101148B (pt) 1999-08-31
DE69230762T2 (de) 2000-07-13
CA2123303C (en) 2003-07-01
KR940703921A (ko) 1994-12-12
AU678144B2 (en) 1997-05-22
WO1993013210A1 (en) 1993-07-08
PT101148A (pt) 1994-03-31
GR3033474T3 (en) 2000-09-29

Similar Documents

Publication Publication Date Title
ATE268818T1 (de) Ctla4-mutantmoleküle und deren verwendung
GR3034524T3 (en) Mixed specificity fusion proteins.
NL300303I2 (nl) CTL4A receptor, fusie-eiwitten die deze receptor bevatten, en toepassing ervan.
DK0613944T3 (da) Fremgangsmåder til regulering af immunresponset under anvendelse af CTLA4-bindende molekyler og IL4-bindende molekyler
AU577745B2 (en) Somatic human hybridoma fusion partner for the production of human monoclonal antibodies
EP0528931A4 (en) Humanized chimeric anti-icam-1 antibodies, methods of preparation and use
WO1995034320A3 (en) Methods for inhibiting antigen specific t cell responses
ES2133139T3 (es) Hetero anticuerpos biespecificos con funciones efectoras dobles.
IL97023A (en) Method of activating cytolytic activity of lymphocytes using anti- cd28 antibody
MX9207420A (es) Moleculas de fusion solubles, con enlace especifico para las moleculas de adhesion de las celulas.
AU3063297A (en) Cellular internalization of pigr stalk and associated ligands
GB1520162A (en) Bone joint prosthesis
TR199700790T1 (xx) S�bstit�te edilmi� heterosikloalkenler.
WO1987007302A3 (en) MONOCLONAL ANTIBODIES TO HUMAN LYMPHOCYTE IgE RECEPTORS, HYBRIDOMAS PRODUCING SUCH ANTIBODIES, AND KITS FOR USING SUCH ANTIBODIES
DK439086D0 (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
Kaldany et al. In vitro stimulation of unprimed lymphocytes by allogeneic semi-soluble lymphocyte membrane fragments
Krammer MURINE T-CELL LYMPHOMAS, A MODEL SYSTEM FOR MOUSE T CELLS